Zentiva

Zentiva, the generic platform of the Sanofi Group, is the third largest generic manufacturer in Europe and one of the fastest growing companies.

Zentiva, which dates back to the 15th century, is a reliable partner for patients, doctors, pharmacists and distributors in all therapeutic areas of the generic pharmaceutical market, providing high quality medicines at an affordable price that meet the needs of patients for modern treatment and prevention.

Zentiva today is more than 800 million potential patients, for whom the company supplies medicines to the markets of 35 countries. Zentiva maintains a leading position in several pharmaceutical markets, namely Russia, the Czech Republic, Romania, Slovakia and Turkey, and is successfully expanding its business in the international arena.

Meeting the needs of its patients for modern and affordable methods of treatment and prevention, Zentiva is constantly developing its portfolio of drugs. Today there are more than 400 brands of high quality medicines covering key therapeutic areas such as cardiovascular diseases, gastrointestinal diseases, urology, women's health, pain relievers, and central nervous system diseases.

Zentiva has four production centers in Central and Eastern Europe, which enable it to manufacture and distribute products in all its markets quickly and efficiently. During production and delivery, the company adheres to the highest quality and safety standards. With a modern production facility of around 3,000 employees and an annual production of 440 million units, Zentiva is one of the largest pharmaceutical manufacturers in Europe.

Zentiva not only manufactures high-quality generic drugs, but also provides training and support programs for doctors and patients, offering the most modern approaches to the treatment of many diseases.

Zentiva is one of the key growth platforms for the Sanofi Group, offering high quality, affordable and reliable medicines to patients and healthcare professionals in Europe.